New answers raise new questions in pulmonary arterial hypertension

Eur Respir J. 2004 Jun;23(6):799-801. doi: 10.1183/09031936.04.00029304a.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Bosentan
  • Endpoint Determination / standards*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Pulmonary Artery
  • Randomized Controlled Trials as Topic*
  • Sulfonamides / therapeutic use*

Substances

  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan